scispace - formally typeset
Y

Yasuhiko Tabata

Researcher at Kyoto University

Publications -  601
Citations -  21043

Yasuhiko Tabata is an academic researcher from Kyoto University. The author has contributed to research in topics: Gelatin & Basic fibroblast growth factor. The author has an hindex of 70, co-authored 601 publications receiving 18737 citations. Previous affiliations of Yasuhiko Tabata include Hokkaido College of Pharmacy & The Nippon Dental University.

Papers
More filters
Journal ArticleDOI

Simple PEG modification of DNA aptamer based on copper ion coordination for tumor targeting.

Yoshimasa Takafuji, +2 more
- 01 Jan 2011 - 
TL;DR: The Cu2+-coordinated PEG modification is a simple and promising method to enhance accumulation of the aptamer in the tumor, resulting in the augmented anti-tumor effect.
Journal ArticleDOI

Use of the buccal fad pad for vocal cord augmentation

Etsuyo Tamura, +3 more
- 01 Jan 2008 - 
TL;DR: Therapeutically successful intracordal injection of autologous fat harvested from the buccal fat pad is performed as vocal rehabilitation in patients with deficient glottal closure and phonation showed notable improvement that was maintained throughout follow-up.
Journal ArticleDOI

Coadministration of adipose-derived stem cells and control-released basic fibroblast growth factor facilitates angiogenesis in a murine ischemic hind limb model

Hisako Horikoshi-Ishihara, +6 more
- 01 Dec 2016 - 
TL;DR: It is suggested that coadministration of ASCs and control-released bFGF facilitates angiogenesis in terms of vessel maturation in a murine ischemic hind limb model.
Journal ArticleDOI

Controlled Release and Antitumor Effect of Pluronic F127 Mixed with Cisplatin in a Rabbit Model

Akinaga Sonoda, +7 more
- 01 Feb 2010 - 
TL;DR: It is concluded that pluronic is useful for the controlled release of cisplatin in a rabbit model and in animals with liver tumors, the delivery of pluronic + cisplatin produced higher tumor reduction rates than in the other groups, without apparent damage to normal liver tissue.
Journal ArticleDOI

Delivery of interleukin-12 in gelatin hydrogels effectively suppresses development of transplanted colonal carcinoma in mice.

Lili Liu, +5 more
- 01 Jan 2003 - 
TL;DR: The results suggest that IL-12 is effective in suppressing the growth of colon carcinoma, and that delivery of this agent in GH is efficient in the treatment of carcinoma.